CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Controlled, Double-blind, Single Center，Clinical Trial to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05076851
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:26.980248+00:00
Published At: 2021-10-13T00:00:00+00:00
Record Updated At: 2021-10-13
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoadjuvant Therapy \\High Risk Prostate Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-10-13"
protocolSection.identificationModule.nctId: "NCT05076851"
protocolSection.identificationModule.officialTitle: "A Randomized, Controlled, Double-blind, Single Center\uff0cClinical Trial to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy\uff08ADT\uff09for High Risk Prostate Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.